Curtin Medical School Curtin University Perth Australia

Department of Clinical Haematology Oncology Blood and Marrow Transplantation Perth Children's Hospital Perth Australia

Department of Clinical Research Saitama Children's Medical Center Saitama Japan

Department of Hematology and Oncology for children and adolescents Sapporo Hokuyu Hospital Sapporo Japan

Department of Paediatrics and Adolescent Medicine The University of Hong Kong Hong Kong

Department of Pathology Institut d'Investigacions Biomèdiques August Pi i Sunyer Barcelona Spain

Department of Pediatric and Adolescent Oncology Gustave Roussy Cancer Campus Paris Sacaly University Villejuif France

Department of Pediatric Hematology and Oncology Charles University and University Hospital Motol Prague Czech Republic

Department of Pediatric Hematology and Oncology Cliniques universitaires Saint Luc UC Louvain Brussels Belgium

Department of Pediatric Hematology and Oncology Department of Pediatrics University Hospital Liège Liège Belgium

Department of Pediatric Hematology and Oncology Federal Center for Pediatric Hematology Oncology and Immunology Moscow Russia

Department of Pediatric Hematology and Oncology Hospital Clínico Universitario Biomedical Research Institute INCLIVA Valencia Spain

Department of Pediatric Hematology and Oncology Schneider Children's Medical Center Petah Tikva and Faculty of Medicine Tel Aviv University Tel Aviv Israel

Department of Pediatric Hematology and Oncology St Anna Children's Hospital Medical University of Vienna Vienna Austria

Department of Pediatric Hematology and Oncology University Hospital La Fe of Valencia Valencia Spain

Division of Hematology and Oncology Department of Pediatrics Hospital for Sick Children Toronto Canada

Hematopathology Section Department of Pathology University Hospital Schleswig Holstein Kiel Germany

Hematopathology section Pathology Department Hospital Clinic of Barcelona University of Barcelona Barcelona Spain

Leukaemia Translational Research Laboratory Telethon Kids Cancer Centre Telethon Kids Institute University of Western Australia Perth Australia

Maternal and Child Health Department Pediatric Hematology Oncology and Stem Cell Transplant Center University of Padova Padova Italy

Pediatric Clinic Semmelweis University Budapest Hungary

Pediatric Hematology and Oncology and NHL BFM Study Center Medical Center Hamburg Eppendorf Hamburg Germany

Pediatric Hematology and Oncology and NHL BFM Study Center University Hospital Münster Münster Germany

Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

St Anna Children's Cancer Research Institute Vienna Austria

Zobrazit více v PubMed

Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720–1748. PubMed PMC

Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. PubMed PMC

Au-Yeung RKH, Arias Padilla L, Zimmermann M, et al. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Br J Haematol. 2020;190(5):753–763. PubMed

Quintanilla-Martinez L, Laurent C, Soma L, et al. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. Virchows Arch. 2023;483(3):281–298. PubMed PMC

Quintanilla-Martinez L, Sander B, Chan JK, et al. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia. Virchows Arch. 2016;468(2):141–157. PubMed

Salaverria I, Martin-Guerrero I, Burkhardt B, et al. High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas. Genes Chromosomes Cancer. 2013;52(2):150–155. PubMed

Chen L, Al-Kzayer LF, Liu T, Kobayashi N, Nakazawa Y, Koike K. IFR4/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10. Pediatr Blood Cancer. 2017;64(2):311–314. PubMed

Chisholm KM, Mohlman J, Liew M, et al. IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials. Pediatr Blood Cancer. 2019;66(8) PubMed PMC

Czarny J, Andrzejewska M, Zajac-Spychala O, et al. Successful treatment of large B-cell lymphoma in a child with compound heterozygous mutation in the ATM gene. Int J Mol Sci. 2023;24(2) PubMed PMC

Elhodaky M, Gunderman LM, Bachula M, et al. Relapse of large B-cell lymphoma with IRF4 rearrangement associated with SLAM-associated protein deficiency. Pediatr Blood Cancer. 2023;70(9) PubMed

Ramis-Zaldivar JE, Gonzalez-Farre B, Balague O, et al. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. Blood. 2020;135(4):274–286. PubMed PMC

Woessmann W, Quintanilla-Martinez L. Rare mature B-cell lymphomas in children and adolescents. Hematol Oncol. 2019;37(suppl 1):53–61. PubMed

Minard-Colin V, Auperin A, Pillon M, et al. Rituximab for high-risk, mature B-cell non-Hodgkin's lymphoma in children. N Engl J Med. 2020;382(23):2207–2219. PubMed PMC

Pillon M, Mussolin L, Carraro E, et al. Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol. Br J Haematol. 2016;175(3):467–475. PubMed

Rigaud C, Auperin A, Jourdain A, et al. Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: a report from the French LMB study. Pediatr Blood Cancer. 2019;66(9) PubMed

Tsurusawa M, Mori T, Kikuchi A, et al. Improved treatment results of children with B-cell non-Hodgkin lymphoma: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study. Pediatr Blood Cancer. 2014;61(7):1215–1221. PubMed

Woessmann W, Seidemann K, Mann G, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood. 2005;105(3):948–958. PubMed

Jourdain A, Auperin A, Minard-Colin V, et al. Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. AaSociete Francaise des Cancers de l'Enfant study. Haematologica. 2015;100(6):810–817. PubMed PMC

Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7(3):332–339. PubMed

Rosolen A, Perkins SL, Pinkerton CR, et al. Revised International pediatric non-Hodgkin lymphoma staging system. J Clin Oncol. 2015;33(18):2112–2118. PubMed PMC

Frauenfeld L, Castrejon-de-Anta N, Ramis-Zaldivar JE, et al. Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. Blood Adv. 2022;6(7):2361–2372. PubMed PMC

Jiang XN, Yu F, Xue T, et al. IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B-cell lymphoma. Cancer Med. 2023;12(9):10684–10693. PubMed PMC

Streich S, Frauenfeld L, Otto F, et al. Prevalence of IRF4 rearrangement in large B-cell lymphomas of the Waldeyer's ring in adults. Virchows Arch. 2023;482(3):551–560. PubMed PMC

Attarbaschi A, Abla O, Arias Padilla L, et al. Rare non-Hodgkin lymphoma of childhood and adolescence: a consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma. Pediatr Blood Cancer. 2020;67(8) PubMed

Attarbaschi A, Beishuizen A, Mann G, et al. Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "Watch and wait" strategy after complete resection. Ann Hematol. 2013;92(11):1537–1541. PubMed

Xavier AC, Suzuki R, Attarbaschi A. Diagnosis and management of rare paediatric Non-Hodgkin lymphoma. Best Pract Res Clin Haematol. 2023;36(1) PubMed

Ronceray L, Abla O, Barzilai-Birenboim S, et al. Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection. Pediatr Blood Cancer. 2018;65(4) PubMed